Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayumi Shikano

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Frontiers in Medicine|April 30, 2025
Accelerated therapeutic development during COVID-19: insights, regulatory strategies, and recommendations for future pandemic preparednessMiyuki Katayama, Mayumi Shikano
Therapeutic Innovation & Regulatory Science|June 20, 2020
Considerations and Regulatory Challenges for Innovative Medicines in Expedited Approval Programs: Breakthrough Therapy and Sakigake DesignationEiji Kajiwara, Mayumi Shikano
BMJ Open|September 12, 2025
Accelerating clinical development outside the usual regions for future pandemics: a comparative analysis of COVID-19 therapeutic development between the USA and JapanMiyuki Katayama, Mayumi Shikano
Therapeutic Innovation & Regulatory Science|September 1, 2020
Impact of Quality by Design Development on the Review Period of New Drug Approval and Product Quality in JapanEiji Kajiwara, Haruki Kamizato, Mayumi Shikano
Vaccines|October 27, 2022
Points to Consider in the Development and Information Provision of Vaccines for Vaccination during Pregnancy: A SurveyYumiko Nomura, Yuusuke Oohashi, Mayumi Shikano
Therapeutic Innovation & Regulatory Science|June 7, 2021
Dissolution Profiles of Generic Products in Dissolution Media Defined by Japanese Guidelines for Bioequivalence StudiesEiji Kajiwara, Haruki Kamizato, Mayumi Shikano
BMC Pediatrics|April 13, 2025
Clinical data required for the approval of pediatric pharmaceuticals in JapanHisamitsu Haigo, Kenji Matsuda, Mayumi Shikano
Vaccine|January 10, 2024
Issues with infectious disease vaccine introduction into routine vaccination in Japan, and considerations for accelerating the processAtsuko Okumoto, Yumiko Nomura, Shin Okuda, et al.
Clinical and Translational Science|June 19, 2026
Challenges in Implementing Revocation of Oncology Drugs Under Conditional Early Approval in Japan: Regulatory Insights From Comparisons With FDA/EMATakahiro Handa, Arata Tanaka, Mayumi Shikano, et al.
BMJ Open|October 11, 2023
Implementation status and consideration for the globalisation of decentralised clinical trials: a cross-sectional analysis of clinical trial databasesTakahiro Sato, Shota Mizumoto, Midori Ota, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Frontiers in Medicine|April 30, 2025
Accelerated therapeutic development during COVID-19: insights, regulatory strategies, and recommendations for future pandemic preparednessMiyuki Katayama, Mayumi Shikano
Therapeutic Innovation & Regulatory Science|June 20, 2020
Considerations and Regulatory Challenges for Innovative Medicines in Expedited Approval Programs: Breakthrough Therapy and Sakigake DesignationEiji Kajiwara, Mayumi Shikano
BMJ Open|September 12, 2025
Accelerating clinical development outside the usual regions for future pandemics: a comparative analysis of COVID-19 therapeutic development between the USA and JapanMiyuki Katayama, Mayumi Shikano
Therapeutic Innovation & Regulatory Science|September 1, 2020
Impact of Quality by Design Development on the Review Period of New Drug Approval and Product Quality in JapanEiji Kajiwara, Haruki Kamizato, Mayumi Shikano
Vaccines|October 27, 2022
Points to Consider in the Development and Information Provision of Vaccines for Vaccination during Pregnancy: A SurveyYumiko Nomura, Yuusuke Oohashi, Mayumi Shikano
Therapeutic Innovation & Regulatory Science|June 7, 2021
Dissolution Profiles of Generic Products in Dissolution Media Defined by Japanese Guidelines for Bioequivalence StudiesEiji Kajiwara, Haruki Kamizato, Mayumi Shikano
BMC Pediatrics|April 13, 2025
Clinical data required for the approval of pediatric pharmaceuticals in JapanHisamitsu Haigo, Kenji Matsuda, Mayumi Shikano
Vaccine|January 10, 2024
Issues with infectious disease vaccine introduction into routine vaccination in Japan, and considerations for accelerating the processAtsuko Okumoto, Yumiko Nomura, Shin Okuda, et al.
Clinical and Translational Science|June 19, 2026
Challenges in Implementing Revocation of Oncology Drugs Under Conditional Early Approval in Japan: Regulatory Insights From Comparisons With FDA/EMATakahiro Handa, Arata Tanaka, Mayumi Shikano, et al.
BMJ Open|October 11, 2023
Implementation status and consideration for the globalisation of decentralised clinical trials: a cross-sectional analysis of clinical trial databasesTakahiro Sato, Shota Mizumoto, Midori Ota, et al.
Pageof 3